Vemurafenib
GO28399
Approved small_molecule completed
Quick answer
Vemurafenib for Neoplasms is a Approved program (small_molecule) at Hoffmann-La Roche with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hoffmann-La Roche
- Indication
- Neoplasms
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed